Nanoformulation of Brain‐Derived Neurotrophic Factor with Target Receptor‐Triggered‐Release in the Central Nervous System

Publisher： John Wiley & Sons Inc

E-ISSN： 1616-3028|28|6|adfm.201703982-adfm.201703982

ISSN： 1616-301x

Source： ADVANCED FUNCTIONAL MATERIALS, Vol.28, Iss.6, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maternal exposure to 3,3’‐iminodipropionitrile targets late‐stage differentiation of hippocampal granule cell lineages to affect brain‐derived neurotrophic factor signaling and interneuron subpopulations in rat offspring

By  

JOURNAL OF APPLIED TOXICOLOGY, Vol. 35, Iss. 8, 2015-08 ,pp. : 884-894

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low‐level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis

By  

JOURNAL OF BIOPHOTONICS (ELECTRONIC), Vol. 8, Iss. 6, 2015-06 ,pp. : 502-511

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 111-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Central nervous system has a lymphatic system: What's next?

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 4, 2015-11 ,pp. : 347-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accumulating knowledge of the barrier system in the central and peripheral nervous system: What's next?

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 109-110

John Wiley & Sons Inc

Access to resources Recommend Favorite